ARTICLE | Clinical News
CTX DP: Completed Phase II enrollment
June 27, 2016 7:00 AM UTC
ReNeuron completed enrollment in the open-label, U.K. Phase II PISCES II trial evaluating CTX DP comprised of 20 million cells administered intracranially via stereotaxic neurosurgery 2-3 month after ...